LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

Search

Medical Transcription Billing Corp

Gesloten

0

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken

By Trading Economics

Werknemers

3,650

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+99.52% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

677K

75M

Vorige openingsprijs

0

Vorige sluitingsprijs

0

Medical Transcription Billing Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

21 mei 2025, 23:25 UTC

Populaire aandelen

Stocks to Watch: Navitas Semiconductor, Urban Outfitters, Lumen Technologies, LiveRamp

21 mei 2025, 21:57 UTC

Acquisities, Fusies, Overnames

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75 Billion -- Update

21 mei 2025, 21:29 UTC

Acquisities, Fusies, Overnames

Millicom to Acquire Telefónica's Operations in Uruguay

21 mei 2025, 21:01 UTC

Belangrijke Marktbewegers

Nvidia Selects Navitas Semiconductor to Work on Next-Generation 800V HVDC Architecture

21 mei 2025, 20:51 UTC

Acquisities, Fusies, Overnames

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75 Billion

21 mei 2025, 23:49 UTC

Marktinformatie

Gold Edges Higher on Possible Investor Shift Away From Government Bonds -- Market Talk

21 mei 2025, 23:37 UTC

Marktinformatie

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

21 mei 2025, 23:33 UTC

Acquisities, Fusies, Overnames

Vigil Neuroscience: Iluzanebart Return to Licensor Amgen to Occur Prior to Closing of Sanofi Deal

21 mei 2025, 23:32 UTC

Acquisities, Fusies, Overnames

Vigil Neuroscience Sees Sanofi Deal Strengthening Development Path for Oral Small Molecule TREM2 Agonist Program

21 mei 2025, 23:32 UTC

Acquisities, Fusies, Overnames

Vigil Neuroscience: Shareholders to Get Up to $10 a Share in Sanofi Deal >SAN.FR VIGL

21 mei 2025, 23:32 UTC

Marktinformatie
Acquisities, Fusies, Overnames

James Hardie's Weak Update Spurs Questions Before AZEK Vote -- Market Talk

21 mei 2025, 23:31 UTC

Acquisities, Fusies, Overnames

Samsung Biologics: Remaining Entity to Focus on Contract Development & Manufacturing Organization Business

21 mei 2025, 23:30 UTC

Acquisities, Fusies, Overnames

Samsung Biologics: Spun-Off Entity Tentatively Named Samsung Episholdings

21 mei 2025, 23:30 UTC

Acquisities, Fusies, Overnames

Samsung Biologics: Separated Business Entity to Focus on R&D Affiliate Samsungbioepis, New Investment

21 mei 2025, 23:29 UTC

Acquisities, Fusies, Overnames

Samsung Biologics to Spin off R&D Segment Into Separate Holdings Company

21 mei 2025, 23:28 UTC

Winsten

Singtel to Finance Buybacks Via Excess Capital Generated From Asset Recycling >Z74.SG

21 mei 2025, 23:27 UTC

Winsten

Singtel Sets Up S$2.0B Share-Buyback Program >Z74.SG

21 mei 2025, 23:26 UTC

Winsten

Singtel: Net Rose Due to Exceptional Gain From Partial Divestment of Comcentre Headquarters >Z74.SG

21 mei 2025, 23:26 UTC

Winsten

Singtel FY25 Rev S$14.15B Vs. S$14.13B >Z74.SG

21 mei 2025, 23:26 UTC

Winsten

Singtel FY25 Net S$4.02B Vs. Net S$795.0M >Z74.SG

21 mei 2025, 23:23 UTC

Acquisities, Fusies, Overnames

Sanofi: VGL101, Vigil's Second Molecule Program, Isn't Being Acquired

21 mei 2025, 23:22 UTC

Acquisities, Fusies, Overnames

Sanofi Sees No Effect From Vigil Deal on 2025 Outlook >SAN.FR

21 mei 2025, 23:20 UTC

Acquisities, Fusies, Overnames

Sanofi: Vigil Deal Enhances Early-Stage Pipeline, Includes VG-3927, Which Will Be Evaluated in Alzheimer's Disease Study

21 mei 2025, 23:18 UTC

Acquisities, Fusies, Overnames

Sanofi to Buy Vigil Neuroscience for $8 a Share at Closing >SAN.FR VIGL

21 mei 2025, 21:42 UTC

Top Nieuws
Acquisities, Fusies, Overnames

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75B -- Update

21 mei 2025, 21:14 UTC

Acquisities, Fusies, Overnames

Millicom to Acquire Telefónica's Ops in Uruguay

21 mei 2025, 21:07 UTC

Top Nieuws

NBCUniversal Bids for Major League Baseball Rights ESPN Dropped, Sources Say -- WSJ

21 mei 2025, 21:06 UTC

Acquisities, Fusies, Overnames

Uber Stock Is Dropping. Blame Elon Musk and Tesla. -- Barrons.com

21 mei 2025, 20:59 UTC

Top Nieuws

Walmart to Cut 1,500 Jobs -- WSJ

21 mei 2025, 20:52 UTC

Winsten

Snowflake Stock Pops After Earnings Beat -- Barrons.com

Peer Vergelijking

Prijswijziging

Medical Transcription Billing Corp Prognose

Koersdoel

By TipRanks

99.52% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 4.13 USD  99.52%

Hoogste 6 USD

Laagste 2.25 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Medical Transcription Billing Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Financieel

$

Over Medical Transcription Billing Corp

CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services. Its technology-enabled business solutions comprise revenue cycle management services, healthcare claims clearinghouse, and medical coding and credentialing services; electronic health records, practice management software and related capabilities, patient experience management solutions, business intelligence and healthcare analytics platforms, and customized applications, interfaces, and various other technology solutions, as well as artificial intelligence, such as CareCloud cirrusAI, AI-powered clinical decision support, AI-powered virtual support assistant, AI-driven appeals, and CareCloud cirrusAI. In addition, the company provides chronic care management, remote patient monitoring, and telemedicine solutions; and professional and consulting services, workforce augmentation and on-demand staffing, and strategic advisory services. Further, it offers medical practice management services to medical practices comprising appropriate facilities, equipment, supplies, support services, nurses, and administrative support staff, as well as management, bill-paying, and financial advisory services. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.